Effect of Pioglitazone on In-Stent Restenosis after Coronary Drug-Eluting Stent Implantation: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: In-stent restenosis (ISR) remains a common life-threatening complication and some studies have shown that pioglitazone can reduce the incidence of ISR in patients with drug-eluting stents (DES) implantation. We conducted a meta-analysis to assess the effect of pioglitazone in preventing...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ming-duo, Zhang, Yu-hui, Zhu, En-jun, Qiao, Shi-bin, Lv, Shu-zheng, Zhao, Quan-ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184901/
https://www.ncbi.nlm.nih.gov/pubmed/25279761
http://dx.doi.org/10.1371/journal.pone.0109614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184901/
https://www.ncbi.nlm.nih.gov/pubmed/25279761
http://dx.doi.org/10.1371/journal.pone.0109614

Ejemplares similares